Korro Bio Target Price

See Korro Bio's analyst price targets ($15) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$11.62

Average Target Price

$15.00

29.1% upside

1 analysts in the last 4 months

High: $15 | Low: $15

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-05-19	H.C. WainwrightMitchell Kapoor	$15	29.1% upside
2026-03-13	Cantor FitzgeraldSteve Seehouse	$22	89.3% upside
2026-03-13	Raymond JamesRyan Deschner	$23	97.9% upside
2026-02-18	Raymond James	$18	54.9% upside
2026-01-29	H.C. Wainwright	$20	72.1% upside
2026-01-29	Chardan Capital	$15	29.1% upside
2026-01-28	Piper SandlerYasmeen Rahimi	$30	158.2% upside
2026-01-28	William BlairMyles Minter	$10	13.9% downside
2026-01-28	Oppenheimer	$22	89.3% upside
2026-01-27	Cantor FitzgeraldSteve Seedhouse	$21	80.7% upside
2025-04-16	Chardan CapitalKeay Nakae	$25	115.1% upside
2024-10-21	RBC CapitalLuca Issi	$105	803.6% upside
2024-05-15	BMO CapitalKostas Biliouris	$120	932.7% upside
2024-03-28	H.C. Wainwright	$115	889.7% upside
2024-03-27	RBC Capital	$90	674.5% upside

Korro Bio (KRRO) FAQ

As of the most recent data, KRRO shows a target price of $15. Scroll down for historical charts and peer comparison views.

If Korro Bio moved to the average analyst target of $15, shares would be roughly 29.1% higher than $11.62. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Korro Bio's earnings trajectory.

Besides this target price page, Stockcircle has Korro Bio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $15) with ownership activity and broader fundamentals.

Korro Bio's target price is $15; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.